These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9866157

  • 1. [Association of allele polymorphism of dopamine d2 receptors with schizophrenic and affective disorders].
    Golimbet VE, Aksenova MG, Abramova LI, Kaleda VG, Orlova VA, Braga EA, Nosikov VV, Trubnikov VI.
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(12):32-5. PubMed ID: 9866157
    [Abstract] [Full Text] [Related]

  • 2. [Dopamine receptor gene (DRD2) polymorphism in patients with endogenous psychoses with regard to their clinical heterogeneity].
    Golimbet VE, Aksenova MG, Abramova LI, Kaleda VG, Orlova VA, Brusentseva LN, Nosikov VV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(11):50-3. PubMed ID: 11765615
    [Abstract] [Full Text] [Related]

  • 3. [Serotonin receptor gene allele polymorphism (5HTR2A) and clinical pathogenetic characteristics in patients with schizophrenia and schizophrenia spectrum disorders].
    Golimbet VE, Manandian KK, Abramova LI, Orlova VA, Kaleda VG, Oleĭchik IV, Iurov IuB, Trubnikov VI.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(2):36-9. PubMed ID: 10709289
    [Abstract] [Full Text] [Related]

  • 4. Association between different psychotic disorders and the DRD4 polymorphism, but no differences in the main ligand binding region of the DRD4 receptor protein compared to controls.
    Weiss J, Mägert HJ, Cieslak A, Forssmann WG.
    Eur J Med Res; 1996 Jun 25; 1(9):439-45. PubMed ID: 9353244
    [Abstract] [Full Text] [Related]

  • 5. Dopamine D2 receptor Taq IA polymorphism is associated with postoperative nausea and vomiting.
    Nakagawa M, Kuri M, Kambara N, Tanigami H, Tanaka H, Kishi Y, Hamajima N.
    J Anesth; 2008 Jun 25; 22(4):397-403. PubMed ID: 19011779
    [Abstract] [Full Text] [Related]

  • 6. Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole.
    Kwon JS, Kim E, Kang DH, Choi JS, Yu KS, Jang IJ, Shin SG, APLUS study group.
    Eur Neuropsychopharmacol; 2008 Dec 25; 18(12):897-907. PubMed ID: 18786813
    [Abstract] [Full Text] [Related]

  • 7. Insertion/deletion variant (-141C Ins/Del) in the 5' regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. Short communication.
    Stöber G, Jatzke S, Heils A, Jungkunz G, Knapp M, Mössner R, Riederer P, Lesch KP.
    J Neural Transm (Vienna); 1998 Dec 25; 105(1):101-9. PubMed ID: 9588764
    [Abstract] [Full Text] [Related]

  • 8. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
    Miura I, Takeuchi S, Katsumi A, Mori A, Kanno K, Yang Q, Mashiko H, Numata Y, Niwa S.
    J Clin Psychopharmacol; 2012 Feb 25; 32(1):106-9. PubMed ID: 22198450
    [Abstract] [Full Text] [Related]

  • 9. Gender-specific molecular heterosis of dopamine D2 receptor gene (DRD2) for smoking in schizophrenia.
    Lee HS, Kim SH, Lee HJ, Kim L, Lee SK, Jang DW, Lee MS, Son BG, Suh KY, Kim S.
    Am J Med Genet; 2002 Aug 08; 114(6):593-7. PubMed ID: 12210271
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene.
    Mihara K, Kondo T, Suzuki A, Yasui N, Nagashima U, Ono S, Otani K, Kaneko S.
    Psychopharmacology (Berl); 2000 Apr 08; 149(3):246-50. PubMed ID: 10823405
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The combined effect of CYP2D6 and DRD2 Taq1A polymorphisms on the antipsychotics daily doses and hospital stay duration in schizophrenia inpatients (observational naturalistic study).
    Kurylev AA, Brodyansky VM, Andreev BV, Kibitov AO, Limankin OV, Mosolov SN.
    Psychiatr Danub; 2018 Jun 08; 30(2):157-163. PubMed ID: 29930225
    [Abstract] [Full Text] [Related]

  • 14. Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders.
    Arinami T, Itokawa M, Aoki J, Shibuya H, Ookubo Y, Iwawaki A, Ota K, Shimizu H, Hamaguchi H, Toru M.
    Am J Med Genet; 1996 Apr 09; 67(2):133-8. PubMed ID: 8723039
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association study between the Taq1A (rs1800497) polymorphism and schizophrenia in a Brazilian sample.
    Cordeiro Q, Vallada H.
    Arq Neuropsiquiatr; 2014 Aug 09; 72(8):582-6. PubMed ID: 25098474
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study.
    Wu X, Hudmon KS, Detry MA, Chamberlain RM, Spitz MR.
    Cancer Epidemiol Biomarkers Prev; 2000 Oct 09; 9(10):1021-6. PubMed ID: 11045783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.